Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Short-term Investments: 2020-2024

Historic Short-term Investments for Silence Therapeutics (SLN) over the last 3 years, with Dec 2024 value amounting to $26.0 million.

  • Silence Therapeutics' Short-term Investments was N/A to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year change of. This contributed to the annual value of $26.0 million for FY2024, which is 29.66% down from last year.
  • As of FY2024, Silence Therapeutics' Short-term Investments stood at $26.0 million, which was down 29.66% from $37.0 million recorded in FY2023.
  • Silence Therapeutics' 5-year Short-term Investments high stood at $37.0 million for FY2023, and its period low was $1.9 million during FY2020.
  • In the last 2 years, Silence Therapeutics' Short-term Investments had a median value of $31.5 million in 2023 and averaged $31.5 million.
  • Data for Silence Therapeutics' Short-term Investments shows a maximum YoY fell of 29.66% (in 2024) over the last 5 years.
  • Silence Therapeutics' Short-term Investments (Yearly) stood at $1.9 million in 2020, then reached $37.0 million in 2023, then declined by 29.66% to $26.0 million in 2024.